Combination flu and Corona vaccine under review in U.S.

December 11, 2022December 11, 2022 admin

0 0

Spread the love

Read Time:37 Second

Washington/Mainz, Germany – A combination vaccine developed by Biontech/Pfizer that could be used to vaccinate against covid-19 and influenza simultaneously in the future has been placed in an accelerated approval process by the U.S. Food and Drug Administration. The announcement was made Friday by Biontech, a German company based in Mainz, and its U.S. partner Pfizer (New York).

The vaccine combines mRNA-based influenza with a Corona vaccine adapted to the currently prevalent BA.4/BA.5 omicron sublines and wild type.

In early November, the two companies announced the start of a Phase 1 trial of the vaccine. About 180 people between 18 and 64 were to participate in the U.S.

• source: APA/picture: pixabay.com

Share

Facebook

Twitter

Pinterest

LinkedIn

About Post Author

admin

admin@austrianpress.com

https://austrianpress.com

Happy

0 0 %

Sad

0 0 %

Excited

0 0 %

Sleepy

0 0 %

Angry

0 0 %

Surprise

0 0 %

This post has already been read 444 times!

Related posts

• 

  April 16, 2024 admin 0

  Apple cider vinegar: How healthy is it, and should you drink it?

  Spread the loveApple cider vinegar is said to heal the skin, hair, liver, intestines, metabolism, and...

  General Interest 

• 

  April 16, 2024 admin 0

  The worst way to charge your mobile phone: A common mistake many make

  Spread the loveIt’s no secret that we use our mobile phones so much that we sometimes...

  General Interest 

• 

  April 15, 2024 admin 0

  How to clean a bottle to avoid mold and germs

  Spread the loveReusable bottles have the advantage that they help us limit plastic consumption, but they...

  General Interest